Extended Data Table 3 Univariate Cox regression analysis for progression-free survival

From: Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

  1. Univariate Cox regression analysis unadjusted for multiple comparisons. P-values < 0.05 are highlighted in bold.
Back to article page